KPI to produce high blood pressure drugs
KAMPALA Pharmaceutical Industries (KPI) is to start producing high blood pressure drugs, the chief executive officer, Nazeem Mohamed, has said.
By Francis Kagolo
KAMPALA Pharmaceutical Industries (KPI) is to start producing high blood pressure drugs, the chief executive officer, Nazeem Mohamed, has said.
Mohamed said the company was waiting for approval from the National Drug Authority (NDA) to commence production. Currently, hospitals use imported drugs to treat high blood pressure.
“But the NDA sometimes delays us. Like today, the inspector was supposed to be here, but he didn’t come. It is delaying,†Mohammed complained recently, while meeting Uganda People’s Congress president Miria Obote and Lira Municipality MP Jimmy Akena.
Miria and Akena were touring the company premises in Ntinda, Kampala. This was in preparation for KPI’s free malaria treatment outreach programme to be organised in Lira on Saturday.
KPI, one of the largest pharmaceutical manufacturing companies in Uganda, recently launched Formin, a drug which regulates the level of sugar in the blood and reduces the weight of diabetics. Statistics indicate that 80% of diabetics are obese.
Mohamed said the company was also in its final stages of producing drugs for most of the ‘lifestyle’ diseases that are on the increase in the country.
“The more Ugandans get richer, the more they do things that are disastrous to their health. Diseases like diabetes, high blood pressure and ulcers are increasing. They are linked to more wealth, eating too much fat, oils and not exercising,†Mohamed said.
KPI’s human resource manager Consolate Ademson said the one-day malaria outreach programme in Lira is meant to offer free medical services to the people as they return from camps.
She called upon the Government to subsidise drug companies.
KAMPALA Pharmaceutical Industries (KPI) is to start producing high blood pressure drugs, the chief executive officer, Nazeem Mohamed, has said.
Mohamed said the company was waiting for approval from the National Drug Authority (NDA) to commence production. Currently, hospitals use imported drugs to treat high blood pressure.
“But the NDA sometimes delays us. Like today, the inspector was supposed to be here, but he didn’t come. It is delaying,†Mohammed complained recently, while meeting Uganda People’s Congress president Miria Obote and Lira Municipality MP Jimmy Akena.
Miria and Akena were touring the company premises in Ntinda, Kampala. This was in preparation for KPI’s free malaria treatment outreach programme to be organised in Lira on Saturday.
KPI, one of the largest pharmaceutical manufacturing companies in Uganda, recently launched Formin, a drug which regulates the level of sugar in the blood and reduces the weight of diabetics. Statistics indicate that 80% of diabetics are obese.
Mohamed said the company was also in its final stages of producing drugs for most of the ‘lifestyle’ diseases that are on the increase in the country.
“The more Ugandans get richer, the more they do things that are disastrous to their health. Diseases like diabetes, high blood pressure and ulcers are increasing. They are linked to more wealth, eating too much fat, oils and not exercising,†Mohamed said.
KPI’s human resource manager Consolate Ademson said the one-day malaria outreach programme in Lira is meant to offer free medical services to the people as they return from camps.
She called upon the Government to subsidise drug companies.